HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The dopamine D3 receptor antagonist, (+)-S 14297, blocks the cataleptic properties of haloperidol in rats.

Abstract
In contrast to haloperidol, the selective dopamine D3 receptor antagonist, (+)-S 11566 [(+/-)-[7-(N,N-dipropylamino)-5,6,7,8-tetrahydro- naphtho(2,3b)dihydro,2,3-furanel]] and its active isomer, (+)-S 14297, induced neither catalepsy nor reduced conditioned avoidance responses in rats. (+)-S 11566 and (+)-S 14297 did, however, dose-dependently abolish the cataleptic actions of haloperidol. This action was expressed stereospecifically inasmuch as (-)-S 17777, the inactive distomer of (+)-S 14297, was ineffective. Further, the influence of haloperidol upon conditioned avoidance responses was not affected by (+)-S 14297. These data suggest that blockade of dopamine D3 receptors may inhibit the extrapyramidal but not-as based on the conditioned avoidance response paradigm-antipsychotic actions of neuroleptics.
AuthorsM J Millan, H Gressier, M Brocco
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 321 Issue 3 Pg. R7-9 (Mar 05 1997) ISSN: 0014-2999 [Print] Netherlands
PMID9085054 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Antipsychotic Agents
  • Dopamine D2 Receptor Antagonists
  • Drd3 protein, rat
  • Furans
  • Receptors, Dopamine D3
  • 7-(N,N-dipropylamino)-5,6,7,8-tetrahydronaphtho(2,3-b)dihydro-2,3-furan
  • 2-Naphthylamine
  • Haloperidol
Topics
  • 2-Naphthylamine (analogs & derivatives, pharmacology)
  • Animals
  • Antipsychotic Agents (toxicity)
  • Avoidance Learning (drug effects)
  • Catalepsy (chemically induced, physiopathology, prevention & control)
  • Dopamine D2 Receptor Antagonists
  • Dose-Response Relationship, Drug
  • Furans (pharmacology)
  • Haloperidol (toxicity)
  • Male
  • Rats
  • Rats, Wistar
  • Receptors, Dopamine D3
  • Stereoisomerism

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: